Article · 21 Jan 2025
Mini reviewPublished 30 Apr 2022
Short assessment on cell-based therapies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Globally, Congestive Heart Failure (CHF) caused by chronic coronary artery disease is a leading cause of morbidity and mortality. Despite breakthroughs in medical and device therapy, its prevalence is rising. Adult stem cell therapies have emerged as a viable treatment for creating new cardio-myocytes and arteries, and they are expected to reverse functional decline in patients with congestive heart failure who are not candidates for heart transplantation. The greatest favorable outcomes from cell therapy are related with paracrine actions rather than direct differentiation, according to research conducted over the last two decades. Paracrine substances produced by stem cells, such as growth factors, cytokines, and microRNAs reduce scar volume and myocyte apoptosis, boost myocyte proliferation, and activate endogenous cardiac stem cells to create new myocytes.
Keywords
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Heart Research.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Heart Research
- SubjectCardiology
- BylineArticles whose byline prints “Hazel Stewart”

